Trilogy Capital’s Ingredion INGR Stock Holding History

Trilogy Capital’s Portfolio INGR Stock Details INGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,987	Closed	-$292K	–	255
2022 Q4	$292K	Buy	+2,987	New	+$275K	0.02%	207

Other funds holding INGR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

YAM

Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Trilogy Capital's INGR Position: Q1 2023 in Review

Trilogy Capital sold out of Ingredion (INGR) in Q1 2023, closing a stake of 2,987 shares — an estimated $292K sold.

Trilogy Capital first reported a position in INGR in Q4 2022 and held it in 1 quarter. The position peaked at $292K in Q4 2022. 476 funds tracked by Wall St. Rank hold INGR as of Q1 2023.

Trilogy Capital reported no remaining Ingredion position as of Q1 2023 after selling out during the quarter.
Trilogy Capital sold 2,987 Ingredion shares in Q1 2023, an estimated $292K.
Trilogy Capital first reported a position in Ingredion in Q4 2022 and held it in 1 quarter.
Trilogy Capital's Ingredion position peaked at $292K in Q4 2022.
476 funds tracked by Wall St. Rank held Ingredion as of Q1 2023.

Based on Trilogy Capital's 13F filing for Q1 2023, filed 17 Apr 2023.